C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/48 (2006.01)
Patent
CA 2525799
The invention relates to a method for identifying dogs which are genetically normal, heterozygous for, or homozygous for the mutation primarily responsible for Collie eye anomaly (CEA). The method comprises the steps of obtaining a biological sample from a dog and testing DNA in the biological sample for the presence or absence of a 7.8 kilobase deletion within chromosome 37 in which the CEA mutation is located. No deletion is indicative of a normal dog. A deletion on one allele of chromosome 37 is indicative of a dog that is heterozygous for the CEA mutation. A deletion in both alleles of chromosome 37 are indicative of a dog that is homozygous for the CEA mutation. Also provided is a kit for identifying a dog as normal, heterozygous for, or homozygous for the CEA mutation.
Acland Gregory M.
Aguirre Gustavo D.
Akey Dayna
Goldstein Orly
Kukekova Anna V.
Cornell Research Foundation Inc.
Edward Valerie G.
LandOfFree
Diagnostic test for collie eye anomaly does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic test for collie eye anomaly, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic test for collie eye anomaly will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1596473